POZEN is a pharmaceutical company that by utilizing an in-source model and focusing on integrated therapies, has developed and obtained FDA approval of two self-invented products in two years. Funded by these milestone/royalty streams, the company is creating a portfolio of cost-effective, evidence based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage. For more information, visit the company’s Web site: http://www.pozen.com
Let us hear your thoughts below: